Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page displays a new revision label indicating v3.6.4, replacing the previous v3.6.3. This change represents a software version update and does not modify the study data or visible content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study documents now show Revision: v3.6.3, updating from v3.6.2. This indicates an updated protocol/document for the trial.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision changed from v3.6.0 to v3.6.2 on the page, reflecting a newer software release. It is a minor patch update and does not modify the study content or public-facing information.SummaryDifference0.0%

- Check36 days agoChange DetectedThe Locations data were removed, eliminating the list and count of trial sites for this study. This removes a key navigational element that helps users identify where the trial is conducted.SummaryDifference16%

- Check43 days agoChange DetectedEnrollment status on the page now shows 'No longer looking for participants', indicating that recruitment has closed. The page also adds new help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with the revision tag to v3.6.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer now shows Revision: v3.5.5, indicating a newer version of the study record. This update does not alter the study details or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.